Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yong Jiang
Shanghai Allist Pharmaceutical Technology
Shanghai
China
Contact
Shanghai Allist Pharmaceutical Technology
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
222
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Furmonertinib (AST2818) Versus Gefitinib as First-Line Therapy for Locally Advanced or Metastatic
EGFR
Mutation-Positive Non-Small Cell Lung Cancer: A Multi-Center, Double-Blind, Randomized Phase 3 Study (FURLONG)
Number of pages: 53
Posted: 10 Jan 2022
Yuankai Shi
,
Gongyan Chen
,
Xiang Wang
,
Yunpeng Liu
,
Lin Wu
,
Yanrong Hao
,
Chunling Liu
,
Shuyang Zhu
,
Xiaodong Zhang
,
Yuping Li
,
Jiwei Liu
,
Lejie Cao
,
Ying Cheng
,
Hui Zhao
,
Shucai Zhang
,
Aimin Zang
,
Jiuwei Cui
,
Jian Feng
,
Fei Liu
, Yong Jiang and
Chuan Gu
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Harbin Medical University - Department of Medical Oncology, Xuzhou Central Hospital - Department of Medical Oncology, China Medical University - Department of Medical Oncology, Zhengzhou University - Henan Provincial People's Hospital, The People's Hospital of Guangxi Zhuang Autonomous Region - Department of Medical Oncology, Xinjiang Medical University - Department of Pulmonary Medicine, Xuzhou Medical College - Department of Respiratory Medicine, Nantong Tumor Hospital - Department of Medical Oncology, Wenzhou Medical University - Department of Pulmonary and Critical Care Medicine, Dalian University - Department of Oncology, University of Science and Technology of China (USTC) - Department of Respiratory Medicine, Jilin Cancer Hospital - Department of Oncology, Anhui Medical University - Department of Respiratory and Critical Care Medicine, Capital Medical University - Department of Oncology, Hebei University - Department of Medical Oncology, Jilin University (JLU) - Cancer Center, Nantong University - Department of Respiratory Medicine, Shanghai Allist Pharmaceutical Technology, Shanghai Allist Pharmaceutical Technology and Shanghai Allist Pharmaceutical Technology
Downloads
222
(296,389)
View PDF
Download
Abstract:
Furmonertinib, AST2818, NSCLC, EGFR, TKI
Feedback